Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Masahiko Nakatsui"'
Autor:
Kazuki Hamada, Takeshi Abe, Kyoji Kouda, Masahiko Nakatsui, Takashi Kitahara, Kazuto Matsunaga, Yoshiyuki Asai
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:1117-1124
Autor:
Kazuki Hamada, Takeshi Abe, Kyoji Kouda, Masahiko Nakatsui, Takashi Kitahara, Kazuto Matsunaga, Yoshiyuki Asai
Publikováno v:
Clinical Pharmacology & Therapeutics.
Autor:
Yu Uneno, Kei Taneishi, Masashi Kanai, Kazuya Okamoto, Yosuke Yamamoto, Akira Yoshioka, Shuji Hiramoto, Akira Nozaki, Yoshitaka Nishikawa, Daisuke Yamaguchi, Teruko Tomono, Masahiko Nakatsui, Mika Baba, Tatsuya Morita, Shigemi Matsumoto, Tomohiro Kuroda, Yasushi Okuno, Manabu Muto
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183291 (2017)
We aimed to develop an adaptable prognosis prediction model that could be applied at any time point during the treatment course for patients with cancer receiving chemotherapy, by applying time-series real-world big data.Between April 2004 and Septem
Externí odkaz:
https://doaj.org/article/d9f6fb20e126425d8c54d2662cae8d28
Autor:
Makoto Hirata, Teruhiko Yoshida, Masahiko Nakatsui, Yasushi Okuno, Mayumi Kamada, Ryosuke Kojima, Noriko Tanabe, Yoshihisa Tanaka, Atsuko Takagi
SummaryWhile the number of genome sequences continues to increase, the functions of many detected gene variants remain to be identified. These variants of uncertain significance constitute a major barrier to precision medicine 1–3. Although many co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97c43d4bdacb1c41547b51373ed2e696
https://doi.org/10.1101/2021.07.15.452566
https://doi.org/10.1101/2021.07.15.452566
Autor:
Tomohiro Sakuma, Hiroaki Mochizuki, Toshihiko Masui, Mayumi Kamada, Norimitsu Uza, Tadayuki Kou, Masahiko Nakatsui, Masashi Kanai, Tomohiro Kondo, Hidehiko Miyake, Yasushi Okuno, Shigemi Matsumoto, Manabu Muto, Kyoichi Takaori, Yuzo Kodama
Publikováno v:
Oncotarget
// Tomohiro Kondo 1 , Masashi Kanai 1 , Tadayuki Kou 1 , Tomohiro Sakuma 2 , Hiroaki Mochizuki 2 , Mayumi Kamada 3 , Masahiko Nakatsui 3 , Norimitsu Uza 4 , Yuzo Kodama 4 , Toshihiko Masui 5 , Kyoichi Takaori 5 , Shigemi Matsumoto 1 , Hidehiko Miyake
Autor:
Tomohiro Sakuma, Yoshihiro Yamamoto, Junichi Matsubara, Sachiko Minamiguchi, Keita Fukuyama, Hiroshi Seno, Masashi Kanai, Tadayuki Kou, Tomohiro Kondo, Pham Nguyen Quy, Toshihiko Masui, Manabu Muto, Shigemi Matsumoto, Hiroaki Mochizuki, Masahiko Nakatsui, Yuji Eso, Akinori Hiroshima, Kyoichi Takaori, Mayumi Kamada
Publikováno v:
The Oncologist. 24:e1401-e1408
Background Tumor mutational burden (TMB) measured via next-generation sequencing (NGS)-based gene panel is a promising biomarker for response to immune checkpoint inhibitors (ICIs) in solid tumors. However, little is known about the preanalytical fac
Autor:
Sachio Nohara, Masaya Sugiyama, Masashi Mizokami, Ryosuke Kojima, Shigeki Tanishima, Mayumi Kamada, Katsushi Tokunaga, Yasushi Okuno, Eiichiro Uchino, Masahiko Nakatsui, Kenjiro Kosaki
Publikováno v:
Human Genome Variation, Vol 6, Iss 1, Pp 1-5 (2019)
Human Genome Variation
Human Genome Variation
To promote the implementation of genomic medicine, we developed an integrated database, the Medical Genomics Japan Variant Database (MGeND). In its first release, MGeND provides data regarding genomic variations in Japanese individuals, collected by
Publikováno v:
Folia Pharmacologica Japonica. 149:281-287
Autor:
Tadayuki, Kou, Masashi, Kanai, Mayumi, Kamada, Masahiko, Nakatsui, Shigemi, Matsumoto, Yasushi, Okuno, Manabu, Muto
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1825
Recent innovations in next-generation sequencing (NGS) technologies have enabled comprehensive genomic profiling of human cancers in the clinical setting. The ability to profile has launched a worldwide trend known as precision medicine, and the fusi